Sanofi
SNY
$42.78
$0.100.23%
NASDAQ
| 06/30/2025 | 06/30/2025 | 03/31/2025 | |||
|---|---|---|---|---|---|
| Net Income | 126.99% | 126.99% | 442.94% | ||
| Total Depreciation and Amortization | 107.86% | 121.91% | -77.76% | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | -1,527.41% | -1,527.41% | -108.60% | ||
| Change in Net Operating Assets | -- | -- | -- | ||
| Cash from Operations | -24.67% | -24.67% | -43.33% | ||
| Capital Expenditure | -- | -- | -- | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | 1,552.61% | 1,552.61% | -142.96% | ||
| Cash from Investing | 1,420.72% | 1,420.72% | -96.47% | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | -- | -- | -- | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | 187.33% | 187.33% | -133.54% | ||
| Cash from Financing | -609.94% | -609.94% | 84.98% | ||
| Foreign Exchange rate Adjustments | -18.63% | -18.63% | -232.99% | ||
| Miscellaneous Cash Flow Adjustments | 323.35% | 323.35% | -- | ||
| Net Change in Cash | 1,344.57% | 1,344.57% | 168.96% | ||